About Farvatn Venture
Farvatn Venture is a venture capital firm founded in 2016. It is primarily based out of Bergen, Norway. As of Aug 2026, Farvatn Venture is an active investor, having invested in 68 companies, with 2 new investments in the last 12 months. It primarily invests in Seed round in Norway based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Life Sciences and High Tech. Most recently it participated in the $***** Series A round of Birdsview Overall, Farvatn Venture portfolio has seen 4 IPOs and 2 acquisitions including key companies like Honest, Oncoinvent and Nordic Halibut. A lot of funds co-invest with Farvatn Venture, with names like Futurum Ventures sharing a substantial percentage of its portfolio. Farvatn Venture has team of 3 people.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 2 more
Portfolio IPOs
Farvatn Venture's List of Top Investments
Farvatn Venture has a portfolio of 68 companies. Their most notable investments are in Birdsview and Ocean Oasis.Their portfolio spans across Norway, United States, United Kingdom and 4 more locations. They have invested in Enterprise Applications, Life Sciences, High Tech and 24 other sectors, across stages such as Seed, Series A and 2 more. Here is the list of top investments by Farvatn Venture:
1. Honest
Internet-first brand offering multi-category products for babies and women. The product catalog includes cleaning products, makeup, skincare, haircare, diapers & wipes, clothing, gears, hand sanitizers, and more.
Key facts about Honest
- Founded Year: 2011
- Location: Santa Monica (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $496M
- Employee Count: 458 as on Sep 30, 2026
- Investors: Brookside Equity Partners, Fidelity Investments and 19 Others
- Latest Funding Round: Series F, Jun 06, 2018, $*****
- Highlight: Public

2. Ethic
Key facts about Ethic
- Founded Year: 2015
- Location: New York City (United States)
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $183M
- Employee Count: 147 as on Sep 30, 2026
- Investors: Fidelity Investments, State Street Global Advisors and 22 Others
- Latest Funding Round: Series D, Apr 07, 2025, $*****
- Highlight: Editors' Pick
3. Talus
Provider of drug discovery platform for gene regulators. The company provides a functional proteomics platform MARMOT focused on studying full-length GRPs in an unmodified cellular environment. It allows the development of therapeutics against the disease-causing GRPs.
Key facts about Talus
- Founded Year: 2020
- Location: Seattle (United States)
- Valuation: $*****
- Stage: Seed
- Total Funding till date: $19.8M
- Employee Count: 28 as on Aug 31, 2026
- Investors: FundersClub, Washington Research Foundation and 11 Others
- Latest Funding Round: Grant (prize money), Apr 02, 2025, $*****
- Highlight: Editors' Pick
4. Vic.ai
AI-driven AP autonomy and intelligence platform for mid-size to enterprise companies. It offers solutions such as real-time insight, accounting autonomy, AI data prediction, and more.
Key facts about Vic.ai
- Founded Year: 2016
- Location: New York City (United States)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $115M
- Employee Count: 94 as on Sep 30, 2026
- Investors: Costanoa, Cowboy Ventures and 9 Others
- Latest Funding Round: Series C, Dec 13, 2022, $*****
- Highlight: Editors' Pick
5. A-Alpha Bio
Developer of cell-based tool for the measurements of protein interactions. The company offers cell-based platform technology that measures protein interactions with the help of engineered yeast cells. It enhances drug development by measuring protein interactions.
Key facts about A-Alpha Bio
- Founded Year: 2017
- Location: Seattle (United States)
- Stage: Series A
- Total Funding till date: $45.2M
- Employee Count: 49 as on Aug 31, 2026
- Investors: AME Cloud Ventures, Xontogeny and 15 Others
- Latest Funding Round: Grant (prize money), May 21, 2024, $*****
- Highlight: Editors' Pick
Farvatn Venture's Year-on-Year Investment Trends
Farvatn Venture has invested in 68 companies over the last 4 years, with an average of 2 new investments annually in the last 3 years. In 2025, it made 3 investments, while as of Aug 2026, it has made 2 investments in this year. Its most recent first time investment was in BioSort and most recent follow-on round was in Birdsview.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 1 | 2 |
2025 | 3 | 0 | 3 |
2024 | 2 | 0 | 2 |
2023 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
Farvatn Venture's Investments by Stage
Farvatn Venture has made 4 investments in Seed stage with an average round size of $3.04M, 2 investments in Series A stage with an average round size of $6.45M, 1 investment in Post IPO stage with an average round size of $25.2M and 1 investment in Series B stage with an average round size of $10.5M.Stage of entry | No. of Investments |
|---|---|
Seed | 4 |
Series A | 2 |
Post IPO | 1 |
Series B | 1 |
Note: We have considered here, only first round of investments
Farvatn Venture's Investments by Sector
Farvatn Venture has a diverse portfolio, with companies operating in the Environment Tech, Sustainability Tech, Environment, Food and Agriculture Tech and Energy Tech. Notably, it has invested in 58 Tech companies, 47 Enterprise (B2B) companies, 26 Software companies and at least 13 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Environment Tech | 3 |
Sustainability Tech | 3 |
Environment | 2 |
Food and Agriculture Tech | 2 |
Energy Tech | 1 |
Others | 5 |
Note: We have considered here, only first round of investments
Farvatn Venture's Investments by Geography
Farvatn Venture has made most investments in Norway (6), followed by United Kingdom where it has made 1 investment.Country | No. of Investments |
|---|---|
Norway | 6 |
United Kingdom | 1 |
United States | 1 |
Note: We have considered here, only first round of investments
Farvatn Venture's recent investments
Farvatn Venture has made 2 investments in 2026 so far - Birdsview and BioSort.Here are the most recent investments by Farvatn Venture:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Aug 17, 2026 | Norway | Series A | 8537 | ||
Feb 24, 2026 | Norway | Series B | 3027 | [+2] | |
Nov 27, 2025 | Norway | Seed | 8246 | [+1] | |
Sep 23, 2025 | United Kingdom | Series A | 8059 | [+6] | |
Jan 23, 2025 | Norway | Post IPO | 3197 |
IPOs and Publicly Listed companies in Farvatn Venture's Portfolio
4 of Farvatn Venture's portfolio companies have become public. Oncoinvent got listed on the Euronext Exchange (Euronext), in Dec 2024 at marketcap of $14.8M and Tivic Health got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $46.3M.Here are Farvatn Venture's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 13, 2024 | - | - | 9696 | |
Nov 11, 2021 | - | - | 8237 | |
May 05, 2021 | - | - | 9545 | |
- | Jan 23, 2025 | Post IPO | 4887 |
Acquired companies in Farvatn Venture's Portfolio
2 companies from Farvatn Venture's portfolio have been acquired. The most recent acquisition was RemovAid in Apr 2024 by Lifecare for $*****.Here are Farvatn Venture's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 29, 2024 | - | - | 9073 | |
Apr 14, 2023 | - | - | 7692 |
Team profile of Farvatn Venture
Farvatn Venture has a team of 3 members.Co-investors of Farvatn Venture
Over the past 4 years, 38 investors have co-invested in Farvatn Venture's portfolio companies. This includes funds and angels.
- Invested before Farvatn Venture: IndieBio, Europa and 1 other have invested in rounds before Farvatn Venture. There is 1 company where IndieBio has invested before Farvatn Venture and 1 company where Europa has invested before Farvatn Venture.
- Top Co-investors of Farvatn Venture: 27 investors entered a company along with Farvatn Venture. These include investors like Futurum Ventures (2 companies).
- Invested after Farvatn Venture: A total of 8 investors have invested in Farvatn Venture's portfolio after their investments. Top Investors include Sarsia Venture Management (1 company), Butterfly Ventures (1 company) and Proptechfonden (1 company).
Recent News related to Farvatn Venture
•
Noteless scoops €3.5M to cut doctor paperwork with AI clinical notesTech Funding News•Nov 27, 2025•Noteless, Futurum Ventures, Farvatn Venture, RedStone
•
Scindo Secures €4.5 Million to Advance AI Enzyme PlatformStartup Rise EU•Sep 24, 2025•Clay Capital, SynBioVen, Kadmos, IndieBio and 8 others
•
Evari raises $7.5 million to build more efficient heat pumpsImpactAlpha•Mar 26, 2024•Evarithermal, Clean Energy Fuels, Clean Energy Venture Group, Farvatn Venture and 1 other
•
Sumitomo invests in Norwegian biomass-derived CO2 removal firmBioenergy Insight•Jan 22, 2024•Sumitomo, Inherit Carbon Solutions, Farvatn Venture, Arkwright X and 1 other
